Arkolith/Insider Trading/DNTH/Form 4

Carr Edward

CHIEF ACCOUNTING OFFICERDianthus Therapeutics, Inc. /DE/ (DNTH) · full profile →Form 4 · filed Mar 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.6M
Net Open-Market Flow
-$3.6M
Transactions
11
8 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2026Option exercise(M)10K$21.77$218K44K
Mar 12, 2026Option exercise(M)18K$22.07$386K34K
Mar 12, 2026Option exercise(M)16K$17.88$289K16K
Mar 12, 2026Sell(S)16K$80.71$1.3M28K
Mar 12, 2026Sell(S)300$85.53$26K0
Mar 12, 2026Sell(S)200$83.38$17K300
Mar 12, 2026Sell(S)4K$82.66$319K500
Mar 12, 2026Sell(S)23K$81.75$1.9M4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2026Option exercise(M)16K—$064K
Mar 12, 2026Option exercise(M)10K—$050K
Mar 12, 2026Option exercise(M)18K—$043K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001273351-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML